BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18801593)

  • 1. Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma.
    Martins SJ; Takagaki TY; Silva AG; Gallo CP; Silva FB; Capelozzi VL
    Lung Cancer; 2009 Apr; 64(1):105-9. PubMed ID: 18801593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
    Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T
    Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
    Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T
    Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
    Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
    Hsu CP; Shen GH; Ko JL
    Lung Cancer; 2006 Jun; 52(3):349-57. PubMed ID: 16569461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung. A study of 117 patients from Brazil.
    Yamaguchi NH; Lichtenfels AJ; Demarchi LM; da Silva AP; Garippo AL; Alves VF; Michelin C; Azevedo PM; Moya T; Takagaki T; Saldiva PH; Vollmer RT; Capelozzi VL
    Am J Clin Pathol; 2004 Jan; 121(1):78-86. PubMed ID: 14750244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma.
    Anagnostou VK; Syrigos KN; Bepler G; Homer RJ; Rimm DL
    J Clin Oncol; 2009 Jan; 27(2):271-8. PubMed ID: 19064983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
    Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
    J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
    Micke P; Basrai M; Faldum A; Bittinger F; Rönnstrand L; Blaukat A; Beeh KM; Oesch F; Fischer B; Buhl R; Hengstler JG
    Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis.
    Leinonen T; Pirinen R; Böhm J; Johansson R; Ropponen K; Kosma VM
    Lung Cancer; 2006 Mar; 51(3):313-21. PubMed ID: 16423426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer.
    Shao W; Wang W; Xiong XG; Cao C; Yan TD; Chen G; Chen H; Yin W; Liu J; Gu Y; Mo M; He J
    J Surg Oncol; 2011 Dec; 104(7):841-6. PubMed ID: 21721010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression spectra of matrix metalloproteinases in metastatic non-small cell lung cancer.
    Lin TS; Chiou SH; Wang LS; Huang HH; Chiang SF; Shih AY; Chen YL; Chen CY; Hsu CP; Hsu NY; Chou MC; Kuo SJ; Chow KC
    Oncol Rep; 2004 Oct; 12(4):717-23. PubMed ID: 15375490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapy.
    Doherty MK; O'Connor E; Hannon D; O'Reilly A; Yen D; Redmond M; Grogan LM; Hennessy BT; Breathnach OS; Morris PG
    Ir J Med Sci; 2019 Feb; 188(1):69-74. PubMed ID: 29948461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.
    Cordes C; Bartling B; Simm A; Afar D; Lautenschläger C; Hansen G; Silber RE; Burdach S; Hofmann HS
    Lung Cancer; 2009 Apr; 64(1):79-85. PubMed ID: 18760860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
    Liu D; Nakano J; Ishikawa S; Yokomise H; Ueno M; Kadota K; Urushihara M; Huang CL
    Lung Cancer; 2007 Dec; 58(3):384-91. PubMed ID: 17728005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
    Fanelli MF; Chinen LT; Begnami MD; Costa WL; Fregnami JH; Soares FA; Montagnini AL
    Histopathology; 2012 Aug; 61(2):153-61. PubMed ID: 22582975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cyclooxygenase-2,and matrix metalloproteinase-2 expression on prognosis of lung cancer].
    Zhang HZ; Lu ZQ; Xie DR; Li HG; Xiong LH; Zhang H; Chen XB
    Ai Zheng; 2004 Oct; 23(10):1190-3. PubMed ID: 15473933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: proposal for a new prognostic model.
    Mountzios G; Bamias A; Voulgaris Z; Rodolakis A; Vlahos G; Gourgoulis G; Papaiakovou EE; Giannopoulos A
    Gynecol Oncol; 2008 Jan; 108(1):130-5. PubMed ID: 17988722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.